» Articles » PMID: 17627380

Risk Reduction and Health Promotion Behaviors Following Genetic Testing for Adult-onset Disorders

Overview
Journal Genet Test
Date 2007 Jul 14
PMID 17627380
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Although clinical genetic testing is available for over 1,000 inherited disorders, consequences of predictive genetic testing have been most extensively examined for hereditary breast and ovarian cancer (HBOC), hereditary colon cancer, and Huntington disease (HD). These focus primarily on psychological, ethical, legal, and social aspects of genetic testing. Genetic testing may also provide information that can lead to behaviors that promote health and reduce risk for disease, reflecting options available for the disorder for which the person is at risk. However, regardless of condition, people completing a genetic test may inform relatives about the results of the test and implications for their risk to develop the condition. Literature on risk reduction behaviors and communication focuses on families with HBOC or colorectal cancer. Few reports document behaviors for other conditions. This paper presents a systematic review of the research literature on risk reduction and health promotion behaviors following clinical genetic testing for adult onset conditions, primarily HBOC, familial colon cancers, and HD. Insights gleaned from this review are discussed as a basis for planning monitoring of health promotion and risk-reduction behaviors for genetic testing for present and future use.

Citing Articles

Effects of health literacy skills, educational attainment, and level of melanoma risk on responses to personalized genomic testing.

Kaphingst K, Khan E, Meyer White K, Sussman A, Guest D, Schofield E Patient Educ Couns. 2020; 104(1):12-19.

PMID: 32773237 PMC: 7749822. DOI: 10.1016/j.pec.2020.07.019.


Impact of Genetic Testing on Risk-Management Behavior of Black Breast Cancer Survivors: A Longitudinal, Observational Study.

Conley C, Kasting M, Augusto B, Garcia J, Cragun D, Gonzalez B Ann Surg Oncol. 2019; 27(5):1659-1670.

PMID: 31677107 PMC: 7145726. DOI: 10.1245/s10434-019-07982-9.


Cancer communication research in the era of genomics and precision medicine: a scoping review.

Kaphingst K, Peterson E, Zhao J, Gaysynsky A, Elrick A, Hong S Genet Med. 2018; 21(8):1691-1698.

PMID: 30573799 PMC: 7725534. DOI: 10.1038/s41436-018-0402-0.


Presymptomatic genetic testing for hereditary cancer in young adults: a survey of young adults and parents.

Godino L, Turchetti D, Jackson L, Hennessy C, Skirton H Eur J Hum Genet. 2018; 27(2):291-299.

PMID: 30287899 PMC: 6336858. DOI: 10.1038/s41431-018-0262-8.


Anticipated health behaviour changes and perceived control in response to disclosure of genetic risk of breast and ovarian cancer: a quantitative survey study among women in the UK.

Meisel S, Fraser L, Side L, Gessler S, Hann K, Wardle J BMJ Open. 2017; 7(12):e017675.

PMID: 29275340 PMC: 5770899. DOI: 10.1136/bmjopen-2017-017675.